49,277
edits
Difference between revisions of "Renal cell carcinoma with fibromyomatous stroma"
Jump to navigation
Jump to search
Renal cell carcinoma with fibromyomatous stroma (view source)
Revision as of 16:32, 6 March 2025
, 16:32, 6 March 2025→Comparison between some renal tumours with clear cells
| Line 26: | Line 26: | ||
===Comparison between some renal tumours with clear cells=== | ===Comparison between some renal tumours with clear cells=== | ||
{| class="wikitable sortable" | {| class="wikitable sortable" | ||
!Tumour | !Tumour | ||
!CA9 | |||
!CK7 | !CK7 | ||
!CD10 | !CD10 | ||
| Line 33: | Line 34: | ||
|- | |- | ||
|Clear cell renal cell carcinoma | |Clear cell renal cell carcinoma | ||
| +ve box-like (complete membrane) | |||
| -ve (may be focal) | | -ve (may be focal) | ||
| +ve | | +ve | ||
| Line 39: | Line 41: | ||
|- | |- | ||
|Clear cell papillary renal cell tumour | |Clear cell papillary renal cell tumour | ||
| +ve cup-like | |||
| +ve (diffuse) | | +ve (diffuse) | ||
| -ve | | -ve | ||
| Line 44: | Line 47: | ||
| -ve<ref name=pmid37661807>{{cite journal |authors=Li H, Argani P, Halper-Stromberg E, Lotan TL, Merino MJ, Reuter VE, Matoso A |title=Positive GPNMB Immunostaining Differentiates Renal Cell Carcinoma With Fibromyomatous Stroma Associated With TSC1/2/MTOR Alterations From Others |journal=Am J Surg Pathol |volume=47 |issue=11 |pages=1267–1273 |date=November 2023 |pmid=37661807 |doi=10.1097/PAS.0000000000002117 |url=}}</ref> | | -ve<ref name=pmid37661807>{{cite journal |authors=Li H, Argani P, Halper-Stromberg E, Lotan TL, Merino MJ, Reuter VE, Matoso A |title=Positive GPNMB Immunostaining Differentiates Renal Cell Carcinoma With Fibromyomatous Stroma Associated With TSC1/2/MTOR Alterations From Others |journal=Am J Surg Pathol |volume=47 |issue=11 |pages=1267–1273 |date=November 2023 |pmid=37661807 |doi=10.1097/PAS.0000000000002117 |url=}}</ref> | ||
|- | |- | ||
|ELOC-mutated renal cell carcinoma | |ELOC-mutated renal cell carcinoma | ||
| +ve box-like | |||
| +ve | | +ve | ||
| +ve | | +ve | ||
| Line 51: | Line 55: | ||
|- | |- | ||
|Renal cell carcinoma with fibromyomatous stroma | |Renal cell carcinoma with fibromyomatous stroma | ||
| ? | |||
| +ve | | +ve | ||
| +ve | | +ve | ||
| Line 57: | Line 62: | ||
|- | |- | ||
|} | |} | ||
==Molecular== | ==Molecular== | ||
*[[Renal neoplasms with TSC/mTOR pathway mutations|TSC/mTOR pathway mutation]].<ref name=pmid36592877/> | *[[Renal neoplasms with TSC/mTOR pathway mutations|TSC/mTOR pathway mutation]].<ref name=pmid36592877/> | ||